Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...

The announcement additionally noted that throughout 14 months of follow-up, UP421 maintained its pancreatic islet cell ...

On March 10, 2026, the team led by Dr. An Chiying at Shenzhen Hengsheng Hospital, affiliated with Shanghai Fosun Health, ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce ...

An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...

Please provide your email address to receive an email when new articles are posted on . All hybrid closed-loop systems improved time in range and time below range compared with other insulin therapies ...

Please provide your email address to receive an email when new articles are posted on . The proportion of large for gestational age infants was higher with oral agents vs. insulin therapy for women ...

A comprehensive study presented at the Endocrine Society’s ENDO 24 annual meeting has revolutionized understanding of diabetes management during pregnancy. Following 10,117 mother-child pairs for up ...